Journals / Haliç Üniversitesi Fen Bilimleri Dergisi / 2019 / Cilt: 2 - Sayı: 2

The Recent Approaches Applied in the Treatment of Rheumatoid Arthritis

Romatoid Artrit Tedavisinde Uygulanan Güncel Yaklaşımlar

Pages
197–206
Publication Date
2019-09-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, traditional treatments and modern therapeutic approaches applied in the treatment of RA will be discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Rheumatoid arthritis (RA) is a chronic autoimmune that is thought to affect about 1% of the general population, and is a disease caused by the human immune system fighting its own healthy cells in the body.
📊
Key Findings & Data:In patients who have rheumatoid arthritis, progression of connective tissue damage leads to disability, decreased quality of life of patients, and mortality.
💡
Conclusion & Impact:In this review, traditional treatments and modern therapeutic approaches applied in the treatment of RA will be discussed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Romatoid artrit · Modern terapötik yaklaşımlar · Geleneksel tedaviler

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune that is thought to affect about 1% of the general population, and is a disease caused by the human immune system fighting its own healthy cells in the body. RA is a disease that emerges as a result of fighting of human immune system with its own healthy cells. In patients who have rheumatoid arthritis, progression of connective tissue damage leads to disability, decreased quality of life of patients, and mortality. There is not a treatment option yet that treat RA completely. With early diagnosis and the treatment of RA, joint damage progression or formation of damage of 90% of patients can be decelerated. Due to the insufficiency of traditional treatments, up-to-date treatment options are needed for effective and specific treatment of rheumatoid arthritis. In this review, traditional treatments and modern therapeutic approaches applied in the treatment of RA will be discussed.

Özet

Romatoid artrit (RA), genel popülasyonun yaklaşık %1’ini etkilediği düşünülen, bağ dokusu hasarını hedef alan kronik bir otoimmün ve insanın bağışıklık sisteminin vücuttaki kendi sağlıklı hücreleriyle savaşması sonucunda ortaya çıkan bir hastalıktır. Romatoid artritli hastalarda, bağ dokusu hasarının ilerlemesi, sakatlığa, hastaların yaşam kalitesinin azalmasına ve mortaliteye sebep olmaktadır. RA’yı tamamen tedavi eden bir tedavi seçeneği henüz yoktur. RA’nın erken tanısı ve tedavisi ile hastaların %90’ının eklem hasarının ilerlemesi ya da hasar oluşumu yavaşlatılabilir. Geleneksel tedavilerin yetersizliğinden dolayı, romatoid artrit tedavisinin etkili ve spesifik bir biçimde gerçekleşmesi için güncel tedavilere ihtiyaç duyulmaktadır. Bu derlemede, romatoid artrit tedavisinde uygulanan geleneksel tedaviler ve modern terapötik yaklaşımlar ele alınacaktır.

🔖

Cite This Article

AKDAĞ, H., KIRMUSAOĞLU, S. (2019). The Recent Approaches Applied in the Treatment of Rheumatoid Arthritis. Haliç Üniversitesi Fen Bilimleri Dergisi, Cilt: 2 - Sayı: 2, 197–206. https://ajindex.com/articles/762942

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Hashemi, M., Atabaki, M.,Daneshvar, H., et al. Association of PTPN22 rs2476601 and EGFR rs17337023 Gene polymorphisms and rheumatoid arthritis in Zahedan, Southeast Iran. Int J Immunogenet. 40 (4), (2013), 299-305. DOI: https://doi.org/10.1111/iji.12038 J, Becker., KL,Winthrop., Update on rheumatic manifestations of infectious diseases. Curr Opin Rheumatol. 22 (1), (2010), 72-7. DOI: 10.1097/BOR.0b013e328333b9f5. [http://www.who.int/chp/topics/rheumatic/en/ (Erişim tarihi:15 aralık 2018).
  2. B., S., Ma, T., Genovese, M., & Lane Smith, R. et al. Cox-2 Selective Inhibitors and Bone. International Journal of Immunopathology and Pharmacology, (2003), 201–205. DOI: https://doi.org/10.1177/039463200301600303
  3. Furst, DE., Meloxicam: selective COX-2 inhibition in clinical practice. Semin Arthritis Rheum. 26 (1), (1997), 21-27. DOI: https://doi.org/10.1016/S0049-0172(97)80049-2 2002 Update American College of Rheumatology Subcommitee on Rheumatoid Arthtitis Guidelines. Guidelines for the management of rheumatoid arthritis: Arthritis Rheum. 46 (2), (2002), 328-346. DOI: 10.1002/art.10148 Quan, L.,Macromolecular Nanomedicine of Glucocorticoids for the Treatment of Rheumatoid Arthritis. J Nanomed Nanotechol. 4 (1), (2013),126. DOI: 10.4172/2157-7439.1000e126 Kirwan, J., Boers, M., Low dose prednisolone for treatment of RA Annals of the Rheumatic Diseases. 63 (11), (2004), 1533-1534. DOI: http://ard.bmj.com/content/63/11/1533.
  4. Wendling, D., Wijdenes, J., Racadot, E., Therapeutic use of monoclonal anti-CD4 antibody in rheumatoid arthritis. J. Rheumatol. 18 (3), (1991), 325–327. DOI: https://doi.org/10.1046/j.1365-2036.1996.59201000.x
  5. Van de, Putte., Atkins, C., Malaise, M., et al. Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous diseasemodifying antirheumatic drug treatment has failed. Ann. Rheum. Dis. 63, (2004), 508–516. DOI: 10.1136/ard.2003.013052 Jacobs, JWG., Everdingen, AAV., Verstappen, SMM., et al. Followup radiographic data on patients with rheumatoid arthritis who participated in a two-year trial of prednisone therapy or placebo. Arthritis Rheum. 54 (5), (2006), 1422-1428. DOI: https://doi.org/10.1002/art.21809
  6. Smolen, JS., Aletaha, D., Koeller, M., New therapies for treatment of rheumatoid arthritis. Lancet. 370 (9602), (2007), 1861–1874. DOI: 10.1016/S0140-6736(07)60784-3
  7. Parmentier, J., Voss, J., Graff, C., et al. In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494). B